Jump to content

EYLEA® (aflibercept) Injection Reduced Risk of Developing Vision-Threatening Events by 75% After Two Years in Patients with Diabetic Retinopathy


In The News

Recommended Posts

Archived

This topic is now archived and is closed to further replies.



×
×
  • Create New...